Bone Biologics Corporation (BBLG)
$0.46-2.13%Close
SELLCRISIS · day 65
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $825,820
- Beta
- 0.50
- P/E (TTM)
- -0.26
- Short % float
- 2.76%
- Days to cover
- 1.0
- SI change
- +38.1%
- 1W
- -6.12%
- 1M
- -16.36%
- vs SPY 1W
- -6.54%
- vs SPY 1M
- -18.42%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on BBLG?
- LOPJLB’s latest quantitative signal on Bone Biologics Corporation (BBLG) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is BBLG in?
- Bone Biologics Corporation (BBLG) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Bone Biologics Corporation (BBLG) do?
- Bone Biologics Corporation, a medical device enterprise, specializes in fostering bone regeneration for spinal fusion, leveraging its advanced recombinant human protein technology. Its flagship product, NELL-1/DBX, is a unique combination of an osteostimulative recombinant protein designed for precise, targeted control over bone regrowth. The company is currently advancing the NELL-1/DBX Fusion…